Omeprazole Pellets

Anti-Ulcerant (PPIs) • Pellets

Delayed release pellets for GERD, erosive esophagitis, and H. pylori regimens. Tight pellet sizing and durable enteric layers secure acid resistance for MUPS and capsule filling.

7.5%8.5%10%15%22.5%
  • GradeIP / BP / USP / EP
  • Pack Size25/50 kg
  • CertificationsWHO-GMP • ISO 9001

Product overview

Omeprazole is a proton pump inhibitor used in acid-suppression formulations. Because the active is sensitive to acidic conditions, appropriate protective coating is important for delayed-release dosage forms. Rraynex focuses on controlled coating, moisture management, particle-size distribution, and dissolution performance to support consistent pharmaceutical manufacturing.

Key characteristics

  • Enteric-coated delayed-release platform.
  • Uniform pellet size for capsule filling and MUPS applications.
  • Controlled moisture and coating characteristics.
  • Suitable for formulation strengths maintained in the existing Rraynex product portfolio.
  • Technical support for pharmaceutical development, scale-up, and regulatory documentation.

Product specifications

Product
Omeprazole Pellets
Form
Pellets
Therapeutic category
Anti-Ulcerant (PPIs)
Available strengths
7.5%, 8.5%, 10%, 15%, 22.5%
Grade
IP / BP / USP / EP
Pack size
25/50 kg
Site certifications
WHO-GMP, ISO 9001, ISO 14001

Detailed specifications, COA and technical documentation are shared on request.

Supply and enquiries

Rraynex supplies Omeprazole Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.

Send product enquiry Browse all pellets Manufacturing capabilities

Other Omeprazole products from Rraynex

Frequently asked questions

Enquire Now